A detailed history of Imc Chicago, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Imc Chicago, LLC holds 334,630 shares of ALT stock, worth $2.53 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
334,630
Previous 283,292 18.12%
Holding current value
$2.53 Million
Previous $1.88 Million 9.08%
% of portfolio
0.07%
Previous 0.06%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$5.5 - $8.1 $282,359 - $415,837
51,338 Added 18.12%
334,630 $2.05 Million
Q2 2024

Jul 15, 2024

BUY
$5.91 - $10.23 $695,518 - $1.2 Million
117,685 Added 71.06%
283,292 $1.88 Million
Q1 2024

Apr 12, 2024

BUY
$8.22 - $13.81 $278,403 - $467,730
33,869 Added 25.71%
165,607 $1.69 Million
Q4 2023

Feb 09, 2024

BUY
$2.14 - $11.62 $281,919 - $1.53 Million
131,738 New
131,738 $1.48 Million
Q3 2022

Nov 08, 2022

BUY
$10.67 - $22.41 $320,249 - $672,613
30,014 New
30,014 $383,000

Others Institutions Holding ALT

About Altimmune, Inc.


  • Ticker ALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,025,300
  • Market Cap $370M
  • Description
  • Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...
More about ALT
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.